AstaReal® Astaxanthin
Natural health product licensed in Canada
- Licence holder
- AstaReal, Inc.
- NPN or DIN-HM
- 80122796
- Status
- Active licence
- Licence date
- 18 January 2023
- Revision date
- Not provided
- Form
- Bloc
- Route of administration
- Orale
- Application type
- Générale (non traditionelle)
If this product were sold in France
No point flagged by the rules we apply.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| 3,3'-dihydroxy-4,4'-diketo-bêta-carotène Source : Haematococcus pluvialis - whole | 4 mg | Not calculated |
| 3,3'-dihydroxy-4,4'-diketo-bêta-carotène Source : Astaxanthin | 4 mg | Not calculated |
| Vitamine E Source : d-alpha tocophérol | 5 mg AT | Not calculated |
| Vitamine E Source : d-alpha tocophérol | 7.45 UI | Not calculated |
Non-medicinal ingredients
Pectine, Ascorbate de sodium, Jus d'orange concentré, Gélatine, Acide citrique, Sucre, Acide L-lactique, Saveur de fruit naturelle, Eau purifiée, Sirop de maïs, Concentré de jus de pommes
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | minimum: 19 years | 1 Bloc | minimum: 2 Tous les jours ; maximum: 3 Tous les jours |
Uses authorised in Canada
Text supplied in English because no French text is available.
Source of/An antioxidant for the maintenance of good health. Source of/An antioxidant that helps fight/protect (cell) against/reduce (the oxidative effect of/the oxidative damage caused by/cell damage caused by) free radicals. Source of/An antioxidant that protects the fat in body tissues from oxidation. Helps reduce C-reactive protein levels, a clinical marker of inflammation. Helps to decrease oxidative stress. Helps reduce 8- hydroxy-2'-deoxyguanosine, a marker of DNA oxidative damage. Clinically shown to possess antioxidative properties.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
No French warning text available in the imported data.
Source
Official Health Canada record, licence 80122796
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.